← Leaderboards
Tobias Gerhard
Rutgers, The State Univ Of N.J.
$6,199,924
Attributed
$6,199,924
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,160,624 · 3
AHRQ$39,300 · 1
By mechanism
R01$5,734,374 · 2
R21$426,250 · 1
P30$39,300 · 1
Top collaborators
No co-investigators on record.
Most similar at Rutgers, The State Univ Of N.J.
Same institution · by research overlap
- Zhiqiang Tan$1,040,012
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsCharacteristicsDesignAffectElderlyMethodologyInnovationEvidence BaseResearch DesignPublic HealthTreatment GuidelinesDrug UsageClinical MedicineMedicareData ResourcePatient-Focused OutcomesClinically RelevantBaseChronicStructureCardiovascular DiseasesIndexingNon-Insulin-Dependent Diabetes MellitusDose
Grant awards (14)
Research and Data Analysis Core$19,650
P30 · FY2025 · HS · contact PI
A Novel Approach to Examine Within-Class Therapeutic Exchangeability of Medications$518,903
R01 · FY2024 · AG · contact PI
Research and Data Analysis Core$19,650
P30 · FY2024 · HS · contact PI
A Novel Approach to Examine Within-Class Therapeutic Exchangeability of Medications$580,634
R01 · FY2023 · AG · contact PI
Strengthening the Evidence-Base for Drug-Disease Interactions in Older Adults$470,045
R01 · FY2023 · AG · contact PI
A Novel Approach to Examine Within-Class Therapeutic Exchangeability of Medications$607,991
R01 · FY2022 · AG · contact PI
Strengthening the Evidence-Base for Drug-Disease Interactions in Older Adults$573,578
R01 · FY2022 · AG · contact PI
A Novel Approach to Examine Within-Class Therapeutic Exchangeability of Medications$606,674
R01 · FY2021 · AG · contact PI
Strengthening the Evidence-Base for Drug-Disease Interactions in Older Adults$562,383
R01 · FY2021 · AG · contact PI
A Novel Approach to Examine Within-Class Therapeutic Exchangeability of Medications$566,464
R01 · FY2020 · AG · contact PI
Strengthening the Evidence-Base for Drug-Disease Interactions in Older Adults$561,369
R01 · FY2020 · AG · contact PI
Strengthening the Evidence-Base for Drug-Disease Interactions in Older Adults$686,333
R01 · FY2019 · AG · contact PI
Safety of Second Generation Antipsychotics for Adult Depression$193,750
R21 · FY2015 · MH · contact PI
Safety of Second Generation Antipsychotics for Adult Depression$232,500
R21 · FY2014 · MH · contact PI